New distribution agreement will expand Rimidi's reach and further enable the company to meet its mission of optimizing the use of data to achieve better healthcare and outcomes.
ATLANTA--November 15, 2022-- Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, announced today a new distribution agreement with Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. As a result of this new agreement, Rimidi is part of the Henry Schein Medical SolutionsHub, and Henry Schein will offer its clinic, medical group, and health system customers access to Rimidi’s cloud-based software platform, further enhancing efforts to support efficient models of care for chronic disease management.
“We are honored and excited to partner with Henry Schein,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “Henry Schein's reach and reputation across the medical market will allow us to continue to meet our vision of enabling better data for better clinical decision making, that ultimately leads to better care for patients with chronic diseases."
Rimidi is designed to support health care providers with their quality improvement, patient engagement, and workflow optimization objectives. Current clinical use cases of the Rimidi platform include chronic, cardiometabolic conditions, epidemic management, and perioperative care.
“At Henry Schein, we recognize the ever-growing rates of chronic disease and remain committed to helping our customers on their continual journey to provide proactive care,” said Michael Casamassa, Vice President, Solutions and Planning, Henry Schein Medical. “By working with Rimidi, we can bring patient monitoring solutions into the existing workflow so that health care professionals can actively engage patients and further optimize disease management in between visits.”
To learn more about Rimidi and to explore Henry Schein Medical’s full portfolio of solutions, please visit the Henry Schein SolutionsHub at henryscheinsolutionshub.com/product/rimidi-integrated-clinical-management-platform/.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.
Recent News & Insights
Rimidi founder & CEO Lucienne Marie Ide is achieving quality objectives by managing diabetes …
SMART on FHIR is a combination of two standards in the healthcare technology domain: SMART …